$9.74B
$903,000
0.0% of portfolio
51,587
Q3 2025
Reduced 96.54%
$6.76B
$9.18 Million
0.0% of portfolio
279,143
Q3 2025
Reduced 60.97%
$296M
$981,000
0.0% of portfolio
189,821
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 34.52%
$8.3B
$4.11 Million
0.0% of portfolio
49,349
Q3 2025
Added 17.36%
-
$0
0.0% of portfolio
-
Q3 2025
Added 35.96%
$3.85B
$3.01 Million
0.0% of portfolio
45,378
Q3 2025
Added 3.09%
$16.9B
$5.56 Million
0.0% of portfolio
82,537
Q3 2025
Reduced 55.29%
-
$0
0.0% of portfolio
-
Q1 2025
New
$57.9B
$4.72 Million
0.0% of portfolio
21,984
Q3 2025
Added 89.63%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 86.25%
$2.76B
$7.56 Million
0.0% of portfolio
46,068
Q3 2025
Added 8.77%
$204M
$998,000
0.0% of portfolio
264,802
Q3 2025
Added 5.14%
$0
$0
0.0% of portfolio
450,729
Q3 2025
Reduced 18.95%
-
$0
0.0% of portfolio
-
Q3 2025
New
$40.1B
$1.9 Million
0.0% of portfolio
852,659
Q3 2025
Reduced 0.79%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 15.93%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.63%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 67.61%
$1.17B
$4.57 Million
0.0% of portfolio
225,104
Q3 2025
Added 0.91%
$3.29B
$20.5 Million
0.0% of portfolio
1,200,576
Q3 2025
Reduced 47.09%
$12.1B
$18.9 Million
0.0% of portfolio
129,639
Q3 2025
Added 89.24%
$11.1B
$9.35 Million
0.0% of portfolio
281,220
Q3 2025
Reduced 87.57%
$974M
$23.5 Million
0.0% of portfolio
399,246
Q3 2025
Reduced 7.49%
$157M
$9.35 Million
0.0% of portfolio
1,628,529
Q3 2025
Added 4.8%
-
$0
0.0% of portfolio
-
Q3 2025
Added 495.38%
$47B
$668,000
0.0% of portfolio
1,360
Q3 2025
Added 8.63%
$7.56B
$18.7 Million
0.0% of portfolio
659,806
Q3 2025
Added 132.42%
$1.76B
$661,000
0.0% of portfolio
66,077
Q3 2025
Added 0.7%
$1.28B
$458,000
0.0% of portfolio
17,199
Q3 2025
Added 10.12%
$711M
$21.7 Million
0.0% of portfolio
2,026,598
Q3 2025
Added 783.55%
$743M
$3.21 Million
0.0% of portfolio
236,197
Q3 2025
Reduced 18.16%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 16.81%
$284M
$2.57 Million
0.0% of portfolio
288,813
Q3 2025
Added 48.17%
Annaly Capital Management In
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 36.43%
$8.69B
$8.6 Million
0.0% of portfolio
442,300
Q3 2025
Reduced 33.93%
$8.09B
$4.23 Million
0.0% of portfolio
174,293
Q3 2025
Reduced 10.73%
Apellis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 12.06%
$744M
$3.07 Million
0.0% of portfolio
70,492
Q3 2025
New
$1.66B
$5.23 Million
0.0% of portfolio
142,560
Q3 2025
New
$78.4B
$1.36 Million
0.0% of portfolio
10,173
Q3 2025
Reduced 98.77%
-
$0
0.0% of portfolio
-
Q3 2025
Added 24.12%
$2.23B
$11.6 Million
0.0% of portfolio
507,517
Q3 2025
New
$197B
$14.2 Million
0.0% of portfolio
69,452
Q3 2025
Reduced 64.63%
$7.75B
$1.96 Million
0.0% of portfolio
14,698
Q3 2025
Reduced 1.56%
$288M
$1.6 Million
0.0% of portfolio
285,777
Q3 2025
Added 16.5%
$9.8B
$6.17 Million
0.0% of portfolio
160,762
Q3 2025
Reduced 13.95%
$678M
$2.33 Million
0.0% of portfolio
514,083
Q3 2025
Reduced 3.29%
$33.4B
$6.78 Million
0.0% of portfolio
187,514
Q3 2025
Added 11.06%
$3.94B
$19.1 Million
0.0% of portfolio
232,199
Q3 2025
Reduced 3.82%